Recombinant Human EGFRVIII Protein, His-Avi Tag

Scan for product

HEK293表达系统CAR-T肿瘤研究

Product no.93123ES Sizes3 options SourceYeasen · Official

Cat. No. 93123ES25

现货 ¥1,185.00

Qty 1

Enquire now

Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status

93123ES25 25 μg ¥1,185.00 现货 Enquire

93123ES60 100 μg ¥3,985.00 现货 Enquire

93123ES76 500 μg ¥13,255.00 现货 Enquire

Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen

Cat.No93123ES

Specification高纯度、高活性、低内毒素、高批间一致性

Origin翌圣生物科技(上海)股份有限公司

技术平台 HEK293表达系统

应用方法 CAR-T靶点蛋白 肿瘤研究EGFRvIII相关机制研究

适用物种种属人

检测方法 ELISA SDS-PAGE LAL法

生物特性参数 蛋白类型重组蛋白/靶点蛋白 种属来源人 生物活性【ELISA Data】Immobilized Human EGFRVIII His Tag at 1μg/ml (100μl/Well) on the plate. Dose response curve for Anti-EGFRVIII Antibody hFc Tag with the EC50 of 9.6ng/ml determined by ELISA. 应用CAR-T靶点；肿瘤研究 产品别称ErbB EC 2.7.10 EC 2.7.10.1 EGFR mENA LEGFR ERBB ERBB1 HER1 PIG61 NISBD2 描述EGFRvIII is tumor specific and has not been found in normal tissues. EGFRvIII is highly tumorigenic and can cause aggressive tumor phenotype with increased invasion proliferation angiogenesis and evasion of apoptosis.

样本类型 重组蛋白

技术参数纯度> 95% as determined by SDS-PAGE. 内毒素水平< 1.0 EU per μg by the LAL method. 分子量The protein has a predicted MW of 40.28 kDa. And it migrates as 55-70 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation. 制剂形式Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). 储存条件-25 ~ -15℃保存，收到货之后有效期1年。复溶后，无菌条件下，-85 ~ -65℃保存，3个月有效期。 表达系统HEK293 标签C-His-Avi AccessionNP_001333870 表达序列Leu25-Ser378 外观Lyophilized Powder 复溶方法开盖之前，先离心。使用无菌水复溶冻干的蛋白质，复溶浓度超过100 μg/mL。建议首次使用时将蛋白分装为每次实验用量，避免反复冻融。